RECENT STORIES:

Addressing digital sovereignty in a data-driven world
What could be the backbone of next-gen digital innovation?
MGM China Reports 2025 Third-Quarter Results
I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NB...
Parcel Perform Defines ‘GEO’ for E-Commerce with Launch of...
ReTo Provides Update on Strategic Refocus Following Recent Leadership ...
LOGIN REGISTER
DigiconAsia
  • Features
    • Featured

      Leveraging CRM platform for AI-powered financial inclusion in Asia

      Leveraging CRM platform for AI-powered financial inclusion in Asia

      Friday, October 17, 2025, 2:34 PM Asia/Singapore | Features
    • Featured

      From smart cities to strained cities?

      From smart cities to strained cities?

      Thursday, October 16, 2025, 1:43 PM Asia/Singapore | Data Centers & Interconnectivity, Features
    • Featured

      Storage for AI, AI for storage

      Storage for AI, AI for storage

      Tuesday, October 7, 2025, 3:57 PM Asia/Singapore | Features
  • News
    • Featured

      International trade-outlook survey reveals key themes in tariff worries, business resilience measures

      International trade-outlook survey reveals key themes in tariff worries, business resilience measures

      Wednesday, October 29, 2025, 11:29 AM Asia/Singapore | News, Newsletter
    • Featured

      Zero click vulnerability found within a day in new AI-powered browser

      Zero click vulnerability found within a day in new AI-powered browser

      Friday, October 24, 2025, 3:18 PM Asia/Singapore | News, Newsletter
    • Featured

      Can poor social media content cause irreversible GenAI brain rot?

      Can poor social media content cause irreversible GenAI brain rot?

      Thursday, October 23, 2025, 4:06 PM Asia/Singapore | News, Newsletter
  • Perspectives
  • Tips & Strategies
  • Whitepapers
  • Awards 2023
  • Directory
  • E-Learning

Select Page

Features

Unlocking AI’s full potential in clinical trials

By Victor Ng | Wednesday, September 17, 2025, 5:24 PM Asia/Singapore

Unlocking AI’s full potential in clinical trials

What are some hurdles pharmaceutical and healthcare organizations need to navigate to succeed with AI?

Ng: One key hurdle is the lack of a unified strategy. A recent McKinsey & Company survey found that about 75% of respondents say their organizations lack a comprehensive vision for gen AI or a strategic roadmap with clearly defined success measures tied to business priorities. Organizations must address this by implementing an enterprise-wide vision, as without it, it is difficult to sustain momentum or scale promising pilots.

Another challenge lies in data fragmentation. While pharmaceutical companies generate massive volumes of data from clinical trials, much of it remains siloed. Without a unified data foundation, AI models struggle to generate actionable insights, ultimately slowing innovation and decision-making.

To overcome this, organizations should consider investing in integrated, end-to-end platforms that connect data across the entire value chain. Medidata’s end-to-end unified platform, for example, manages the full clinical trial lifecycle from study design and patient recruitment to monitoring, data analysis, and results reporting. Such unified approach helps break down data silos and creates a consistent, high-quality dataset that supports more effective use of AI across the board.

Risk management is also a critical area that is often under-addressed. The McKinsey survey found that 35% of respondents spend fewer than 10 hours collaborating with risk counterparts. This signals that risk mitigation is not sufficiently embedded in AI development processes, which is especially important now as we see gen AI introducing novel risks, including hallucinations, bias, IP exposure, and data privacy issues.

At Medidata, we believe that these risks must be proactively managed across the entire lifecycle, not just treated as compliance checkpoints. We are focused on leveraging AI across every stage of the clinical trial process including the identification and management of potential risks. This includes integrating AI analytics that enable real-time risk monitoring, as well as developing pioneering innovations like Medidata Simulants, which uses gen AI to produce high-fidelity synthetic data based on a database of over 36,000 clinical trials, and helps to uncover potential risks early.

What’s key though is that while genAI can support decision-making, it should not replace human judgment. Guardrails are essential, including human review of AI-generated content, especially when it influences treatment decisions or patient communication.

How would a fully AI-integrated clinical workflow look like, and what regulatory and operational shifts are needed?

Ng: A fully AI-integrated clinical workflow would embed intelligent, data-driven decision-making across every stage of drug development. AI does not simply enhance isolated processes, but it transforms the entire ecosystem. Specifically, AI would play a strategic role across:

  • Trial design: AI enables organizations to make more informed decisions when selecting and designing clinical development programs by simulating different trial scenarios and identifying the most effective study designs.
  • Planning & execution: It helps accelerate trial timelines by optimizing site selection. AI can also reduce operational costs and enhance quality through better recruitment planning and real-time risk management.
  • Regulatory filing: AI improves the way data is organized and analyzed, allowing sponsors to better demonstrate a treatment’s value to regulators, payers, and patients through clearer, more comprehensive evidence.
  • Commercialization & medical use: It strengthens the clinical evidence base and supports personalized treatment strategies, helping ensure that the right therapies reach the right patients at the right time.

AI integration is also essential in decentralized clinical trials (DCTs), which depend heavily on digital technologies like remote monitoring, electronic informed consent (eConsent), and electronic clinical outcome assessments (eCOA). These tools generate complex, real-time data, and AI supports the management of this data. It can further ensure data quality and integrity throughout the trial.

AI’s role will expand beyond research operations and into patient relationships. By 2040, we anticipate a landscape where AI is woven throughout the healthcare journey, which enables personalized treatments, seamless data sharing, and more responsive care.

This shift will require reimagining not only the technical architecture of trials but also the regulatory frameworks that govern them.

To enable this future, regulators and industry sponsors must collaborate closely to validate and evolve new AI-driven methodologies. Flexibility must go hand-in-hand with scientific rigor to maintain trust and safety, and there is also a need to ensure inclusivity. With intuitive interfaces and adequate support, even patients less familiar with digital tools can participate confidently.

The goal should be to design trials that adapt to patients’ lives and not the other way around.

Pages: 1 2

Share:

PreviousG-P Named an Industry Leader in NelsonHall’s Global Employer of Record (EOR) Market Analysis for Fifth Consecutive Report
NextThe 2025 BRICS Forum on Partnership for New Industrial Revolution opened in Xiamen, Fujian Province.

Related Posts

From phishing to card testing to $0 payments: Unpacking fraud trends and defenses

From phishing to card testing to $0 payments: Unpacking fraud trends and defenses

April 2, 2025

Intelligent automation in financial services

Intelligent automation in financial services

June 16, 2023

How AI can go hand-in-hand with HR

How AI can go hand-in-hand with HR

September 29, 2023

India’s ambition to be a crypto-innovation hub: Is it too far-fetched?

India’s ambition to be a crypto-innovation hub: Is it too far-fetched?

June 21, 2021

Leave a reply Cancel reply

You must be logged in to post a comment.

Awards Nomination Banner

gamification list

PARTICIPATE NOW

top placement

Whitepapers

  • Achieve Modernization Without the Complexity

    Achieve Modernization Without the Complexity

    Transforming IT infrastructure is crucial …Download Whitepaper
  • 5 Steps to Boost IT Infrastructure Reliability

    5 Steps to Boost IT Infrastructure Reliability

    In today's fast-evolving tech landscape, …Download Whitepaper
  • Simplify Payroll Setup for Your Small Business

    Simplify Payroll Setup for Your Small Business

    In our free guide, "How …Download Whitepaper
  • Overcoming the Challenges of Cost & Complexity in the Cloud-first Era.

    Overcoming the Challenges of Cost & Complexity in the Cloud-first Era.

    Download Whitepaper

Middle Placement

Case Studies

  • Globe Business reduces overall customer service workload by 34% through digitalization

    Globe Business reduces overall customer service workload by 34% through digitalization

    This was the result of …Read More
  • HOSTWAY gains 73% operational efficiency for private cloud operations  

    HOSTWAY gains 73% operational efficiency for private cloud operations  

    With NetApp storage solutions, the …Read More
  • Designing unmanned aerial vehicles for safety and speed

    Designing unmanned aerial vehicles for safety and speed

    SwissDrones uses Autodesk Fusion to …Read More
  • LVMH redefines payments in the global luxury sector with Adyen

    LVMH redefines payments in the global luxury sector with Adyen

    Frictionless payment solutions for seamless …Read More

Bottom Sidebar

Other News

  • MGM China Reports 2025 Third-Quarter Results

    October 30, 2025
    Record Third Quarter  Adjusted EBITDA …Read More »
  • I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform

    October 29, 2025
    New corporate brand reflects strategic …Read More »
  • Parcel Perform Defines ‘GEO’ for E-Commerce with Launch of AI Commerce Visibility

    October 29, 2025
    Brands can now track, analyze …Read More »
  • ReTo Provides Update on Strategic Refocus Following Recent Leadership Transition

    October 29, 2025
    BEIJING, Oct. 29, 2025 /PRNewswire/ …Read More »
  • Yoken, Private Label of Boqii Holding Limited, Joins Hands with High-End Hotels to Redefine “Travelling with Pets”

    October 29, 2025
    SHANGHAI, Oct. 29, 2025 /PRNewswire/ …Read More »
  • Our Brands
  • CybersecAsia
  • MartechAsia
  • Home
  • About Us
  • Contact Us
  • Sitemap
  • Privacy & Cookies
  • Terms of Use
  • Advertising & Reprint Policy
  • Media Kit
  • Subscribe
  • Manage Subscriptions
  • Newsletter

Copyright © 2025 DigiconAsia All Rights Reserved.